Mylanta One Antacid/anti-gas Tablet, Chewable
NDC Package 62372-552-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Mylanta One Antacid/anti-gas (calcium carbonate, magnesium hydroxide, dimethicone) tablets is ▪adults and children 12 years and over: chew 1 tablet as symptoms occur, or as directed by doctor▪do not take more than 6 tablets in 24 hours▪do not use the maximum dosage for more than 2 weeks▪children under 12 years of age: ask a doctor. This formulation utilizes a tablet, chewable delivery system. Marketed by Infirst Healthcare Inc., this product is identified by NDC 62372-552 and is authorized under FDA application M001.

Identification & Billing

NDC Package Code
62372-552-50
Package Description
50 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
62372-552
11-Digit Billing Format
62372055250
RxNorm Crosswalk
  • RxCUI: 2556794 - calcium carbonate 1000 MG / magnesium hydroxide 270 MG / dimethicone 80 MG Chewable Tablet
  • RxCUI: 2556794 - calcium carbonate 1000 MG / magnesium hydroxide 270 MG / simethicone 80 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Mylanta One Antacid/anti-gas
Non-Proprietary Name
Calcium Carbonate, Magnesium Hydroxide, Dimethicone
Substance Name
Calcium Carbonate; Dimethicone; Magnesium Hydroxide
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
▪adults and children 12 years and over: chew 1 tablet as symptoms occur, or as directed by doctor▪do not take more than 6 tablets in 24 hours▪do not use the maximum dosage for more than 2 weeks▪children under 12 years of age: ask a doctor

Regulatory & Marketing

Labeler Name
Infirst Healthcare Inc.
Product Type
Human Otc Drug
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-04-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62372-552). Click a package code to view its specific billing and regulatory data.

62372-552-51
50 TABLET, CHEWABLE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62372-552-50 identifies a specific commercial package of 50 tablet, chewable in 1 bottle, plastic of Mylanta One Antacid/anti-gas, a human over the counter drug labeled by Infirst Healthcare Inc.. This tablet, chewable is formulated for oral use and contains calcium carbonate; dimethicone; magnesium hydroxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Infirst Healthcare Inc. on May 04, 2021. The current certification is valid through December 31, 2026.

How is this Infirst Healthcare Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62372055250. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62372-552-50
11-Digit CMS (5-4-2)
62372-0552-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.